With input costs continuing to rise, automaker like Tata Motors are looking to increase vehicle prices from January next year to offset the...

As per the report by the USFDA, Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due ...

Zydus Pharmaceuticals USA Inc, a subsidiary of Zydus Cadila, is also recalling 7,668 bottles of Carvedilol Tablets, used to treat high bloo...

A drug called carvedilol shows some protective effects against skin cancer, according to researchers.

Read on to know what brokerages have to say about select stocks that are likely to be in action today.

Sun Pharmaceutical Industries today said American health regulator has approved resumption of manufacturing operations at its US-based subs...

Ahmedabad-based ZydusCadila and Israeli generic major Teva have settled their patent disputes over active pharmaceutical ingredients (APIs)...

Crude oil prices fell in Asian trade today after US crude reserves rose higher than expected. New York's main futures contract, light sweet...

Israeli generic major Teva and Mumbai-based Glenmark Pharmaceuticals have settled a patent dispute over various generic versions of Coreg -...

Traders are likely to adjust their portfolio on expectations of important declarations from the government in terms of rate cuts and excise...

Pharma companies are at loggerheads with their foreign counterparts over patent rights. Global pharma giants have been filing cases against...

Ranbaxy Laboratories and Cadila Healthcare have received approval from the USFDA for Carvedilol tablets in the strengths - 3.125 mg, 6.25 m...

Wanbury on Monday said it has agreed to acquire Spanish drugmaker Industria Farmaceutica Cantabri’s branded generic business for Rs 240 cro...

Gleevec, the pill that offered an easy way to target a difficult type of leukemia, may cause serious heart damage, researchers cautioned.